Can Propranolol Be Used for Treating Extrapyramidal Symptoms?
Yes, propranolol (a β-blocker) can be used to treat akathisia, a specific type of extrapyramidal symptom, but it is NOT effective for other extrapyramidal symptoms like dystonia or parkinsonism.
Understanding Which Extrapyramidal Symptoms Propranolol Treats
Extrapyramidal symptoms (EPS) are not a single entity—they include several distinct movement disorders, and propranolol only works for one of them:
Akathisia: Propranolol IS Effective
Propranolol is specifically indicated for akathisia, the subjective sense of severe restlessness with objective motor agitation (pacing, inability to sit still) 1. Multiple guidelines confirm that β-blockers, particularly propranolol, provide relief when antiparkinsonian agents fail 1. The evidence shows lipophilic β-blockers (especially propranolol and metoprolol) are the most effective treatments for akathisia 2.
- First-line approach: Lower the antipsychotic dose if clinically feasible 1
- If dose reduction isn't possible: Propranolol is a primary pharmacologic option alongside benzodiazepines 1, 2
- Typical dosing: Low doses are effective—case reports show success with 10 mg twice daily titrated up to 40 mg four times daily 3, though mean effective doses around 69 mg daily have been reported 4
Dystonia and Parkinsonism: Propranolol Is NOT Effective
For acute dystonic reactions (sudden muscle spasms, oculogyric crisis, torticollis), propranolol has no role. These require anticholinergic medications (like benztropine or diphenhydramine) or antihistamines 1, 5.
For drug-induced parkinsonism (bradykinesia, tremors, rigidity), propranolol is not the treatment. These symptoms respond to anticholinergic agents or amantadine 1.
Clinical Algorithm for EPS Management
Identify the specific EPS type:
- Dystonia (muscle spasms, abnormal postures) → Use anticholinergics/antihistamines
- Parkinsonism (tremor, rigidity, bradykinesia) → Use anticholinergics or amantadine
- Akathisia (restlessness, pacing, subjective distress) → Consider propranolol
For akathisia specifically:
Propranolol dosing for akathisia:
- Start: 10-20 mg twice daily
- Titrate based on response up to 40 mg four times daily
- Monitor for hypotension and bradycardia
Important Caveats
Propranolol has contraindications that must be screened before use: sinus bradycardia, hypotension, heart block greater than first degree, heart failure, reactive airways disease, and hypoglycemia 6. The FDA label does not list EPS treatment as an approved indication 6, so this represents off-label use supported by clinical guidelines.
Akathisia is frequently misdiagnosed as psychotic agitation or anxiety, leading to inappropriate antipsychotic dose increases that worsen the problem 1. High clinical suspicion is essential—look for the combination of subjective restlessness with objective motor signs.
Tardive dyskinesia is different: While one retrospective study showed propranolol improved tardive dyskinesia in 64% of patients 4, this is a separate late-onset movement disorder, not an acute EPS. The evidence for propranolol in tardive dyskinesia is much weaker and based primarily on this single retrospective analysis.
Why This Matters
Children and adolescents are at particularly high risk for EPS compared to adults 1. Akathisia is a common reason for medication noncompliance, which increases relapse risk and morbidity 1. Recognizing akathisia and treating it appropriately with propranolol can be the difference between treatment success and failure.
The 2025 INTEGRATE guidelines emphasize that secondary causes of symptoms (including EPS like akathisia) should be identified and addressed when patients have persistent negative symptoms or appear treatment-resistant 7. Untreated akathisia can masquerade as worsening psychiatric illness.